Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone with calcium channel blocker and/or angiotensin II receptor blocker for hypertension with adrenal hyperplasia
ChiCTR-TRC-09000350Phase 4Completed
- Sponsor
- First Affiliated Hospital of Xinjiang Medical University
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of spironolactone in hypertension (HTN) (4 arms), sponsored by First Affiliated Hospital of Xinjiang Medical University. Primary endpoint: Blood pressure. Started May 2009; status: completed.
02
Drugs
spironolactone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR-TRC-09000350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000350.